
Bijan Ahvazi
Examiner (ID: 16926, Phone: (571)270-3449 , Office: P/1763 )
| Most Active Art Unit | 1763 |
| Art Unit(s) | 1763, 4171, 1761, 1796 |
| Total Applications | 1549 |
| Issued Applications | 974 |
| Pending Applications | 113 |
| Abandoned Applications | 482 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4880525
[patent_doc_number] => 20080153908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition'
[patent_app_type] => utility
[patent_app_number] => 11/933496
[patent_app_country] => US
[patent_app_date] => 2007-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2809
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153908.pdf
[firstpage_image] =>[orig_patent_app_number] => 11933496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/933496 | Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition | Oct 31, 2007 | Abandoned |
Array
(
[id] => 5331259
[patent_doc_number] => 20090111736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Orally-Absorbed Solid Dose Formulation for Vancomycin'
[patent_app_type] => utility
[patent_app_number] => 11/927579
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4934
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111736.pdf
[firstpage_image] =>[orig_patent_app_number] => 11927579
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927579 | Orally-Absorbed Solid Dose Formulation for Vancomycin | Oct 28, 2007 | Abandoned |
Array
(
[id] => 4916251
[patent_doc_number] => 20080096852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'USE OF OCULOSURFACE SELECTIVE GLUCOCORTICOID IN THE TREATMENT OF DRY EYE'
[patent_app_type] => utility
[patent_app_number] => 11/925178
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4294
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925178
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925178 | USE OF OCULOSURFACE SELECTIVE GLUCOCORTICOID IN THE TREATMENT OF DRY EYE | Oct 25, 2007 | Abandoned |
Array
(
[id] => 4658258
[patent_doc_number] => 20080027120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN'
[patent_app_type] => utility
[patent_app_number] => 11/842915
[patent_app_country] => US
[patent_app_date] => 2007-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3133
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842915
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842915 | Ketorolac tromethamine compositions for treating or preventing ocular pain | Oct 16, 2007 | Issued |
Array
(
[id] => 4916365
[patent_doc_number] => 20080096966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'OPHTHALMIC COMPOSITIONS CONTAINING DIGLYCINE'
[patent_app_type] => utility
[patent_app_number] => 11/873703
[patent_app_country] => US
[patent_app_date] => 2007-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5978
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096966.pdf
[firstpage_image] =>[orig_patent_app_number] => 11873703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/873703 | Ophthalmic compositions containing diglycine | Oct 16, 2007 | Issued |
Array
(
[id] => 4676879
[patent_doc_number] => 20080214510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Methods and compositions for treating meibomian gland disease'
[patent_app_type] => utility
[patent_app_number] => 11/974435
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5370
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214510.pdf
[firstpage_image] =>[orig_patent_app_number] => 11974435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/974435 | Methods and compositions for treating meibomian gland disease | Oct 10, 2007 | Abandoned |
Array
(
[id] => 4797890
[patent_doc_number] => 20080009476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'TREATING CONJUNCTIVITIS BY TOPICALLY ADMINISTERING AN EPINASTINE SOLUTION TO THE CONJUNCTIVA'
[patent_app_type] => utility
[patent_app_number] => 11/863008
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1632
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11863008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/863008 | Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva | Sep 26, 2007 | Issued |
Array
(
[id] => 4718710
[patent_doc_number] => 20080241232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Use of green porphyrins to treat neovasculature in the eye'
[patent_app_type] => utility
[patent_app_number] => 11/904018
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6619
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241232.pdf
[firstpage_image] =>[orig_patent_app_number] => 11904018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904018 | Use of green porphyrins to treat neovasculature in the eye | Sep 24, 2007 | Abandoned |
Array
(
[id] => 5465608
[patent_doc_number] => 20090325808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'OSTWALD RIPENING INHIBITION IN CHEMICAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/441844
[patent_app_country] => US
[patent_app_date] => 2007-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4967
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325808.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441844
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441844 | OSTWALD RIPENING INHIBITION IN CHEMICAL FORMULATIONS | Sep 20, 2007 | Pending |
Array
(
[id] => 5508070
[patent_doc_number] => 20090081277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING OCULAR CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/859310
[patent_app_country] => US
[patent_app_date] => 2007-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12519
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11859310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/859310 | PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING OCULAR CONDITIONS | Sep 20, 2007 | Abandoned |
Array
(
[id] => 8689418
[patent_doc_number] => 08388941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Self preserved aqueous pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/441995
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7135
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12441995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441995 | Self preserved aqueous pharmaceutical compositions | Sep 19, 2007 | Issued |
Array
(
[id] => 5485821
[patent_doc_number] => 20090275586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'HETEROCYCLIC INHIBITORS OF PDE4'
[patent_app_type] => utility
[patent_app_number] => 12/444539
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12322
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275586.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444539 | HETEROCYCLIC INHIBITORS OF PDE4 | Sep 19, 2007 | Abandoned |
Array
(
[id] => 4922592
[patent_doc_number] => 20080070908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Compositions including antibiotics and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 11/900942
[patent_app_country] => US
[patent_app_date] => 2007-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7292
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070908.pdf
[firstpage_image] =>[orig_patent_app_number] => 11900942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/900942 | Compositions including antibiotics and methods for using same | Sep 12, 2007 | Abandoned |
Array
(
[id] => 4932485
[patent_doc_number] => 20080003260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin'
[patent_app_type] => utility
[patent_app_number] => 11/900170
[patent_app_country] => US
[patent_app_date] => 2007-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3488
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003260.pdf
[firstpage_image] =>[orig_patent_app_number] => 11900170
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/900170 | Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin | Sep 9, 2007 | Abandoned |
Array
(
[id] => 4772744
[patent_doc_number] => 20080058403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'VISION THROUGH PHOTODYNAMIC THERAPY OF THE EYE'
[patent_app_type] => utility
[patent_app_number] => 11/852965
[patent_app_country] => US
[patent_app_date] => 2007-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3583
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11852965
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/852965 | Vision through photodynamic therapy of the eye | Sep 9, 2007 | Issued |
Array
(
[id] => 4797915
[patent_doc_number] => 20080009501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments'
[patent_app_type] => utility
[patent_app_number] => 11/900175
[patent_app_country] => US
[patent_app_date] => 2007-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3468
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009501.pdf
[firstpage_image] =>[orig_patent_app_number] => 11900175
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/900175 | Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments | Sep 9, 2007 | Abandoned |
Array
(
[id] => 4939474
[patent_doc_number] => 20080076793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Use of an ascomycin for the treatment of blepharitis'
[patent_app_type] => utility
[patent_app_number] => 11/899155
[patent_app_country] => US
[patent_app_date] => 2007-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2767
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11899155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/899155 | Use of an ascomycin for the treatment of blepharitis | Sep 3, 2007 | Abandoned |
Array
(
[id] => 6401811
[patent_doc_number] => 20100179175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'USE OF PKC INHIBITORS IN OCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/377165
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5735
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377165
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377165 | USE OF PKC INHIBITORS IN OCULAR DISEASES | Aug 20, 2007 | Abandoned |
Array
(
[id] => 4771364
[patent_doc_number] => 20080057022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Ophthalmic Pharmaceutical Compositions and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/842394
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4893
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842394
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842394 | Ophthalmic Pharmaceutical Compositions and Uses Thereof | Aug 20, 2007 | Abandoned |
Array
(
[id] => 4705136
[patent_doc_number] => 20080064660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Modulation of Inflammation Related to Columnar Epithelia'
[patent_app_type] => utility
[patent_app_number] => 11/838046
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17246
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064660.pdf
[firstpage_image] =>[orig_patent_app_number] => 11838046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/838046 | Modulation of Inflammation Related to Columnar Epithelia | Aug 12, 2007 | Abandoned |